Kura Oncology Inc (KURA.OQ)
KURA.OQ on NASDAQ Stock Exchange Global Select Market
20.25USD
20 Jul 2018
20.25USD
20 Jul 2018
Change (% chg)
$-0.15 (-0.74%)
$-0.15 (-0.74%)
Prev Close
$20.40
$20.40
Open
$20.40
$20.40
Day's High
$20.55
$20.55
Day's Low
$20.25
$20.25
Volume
7,309
7,309
Avg. Vol
84,135
84,135
52-wk High
$24.00
$24.00
52-wk Low
$5.90
$5.90
Select another date:
Wed, May 9 2018
BRIEF-Kura Oncology Reports Qtrly Loss Per Share Of $0.46
* KURA ONCOLOGY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
BRIEF-Kura Oncology Announces New Patent For Tipifarnib In Hematologic Malignancies
* KURA ONCOLOGY ANNOUNCES NEW PATENT FOR TIPIFARNIB IN HEMATOLOGIC MALIGNANCIES
BRIEF-Kura Oncology Inc - Co Entered Into An Amended And Restated Sales Agreement With Cowen And Company
* KURA ONCOLOGY INC - ON MARCH 12, 2018, CO ENTERED INTO AN AMENDED AND RESTATED SALES AGREEMENT WITH COWEN AND COMPANY, LLC - SEC FILING
BRIEF-Kura Oncology Provides Regulatory Update On Tipifarnib
* KURA ONCOLOGY PROVIDES REGULATORY UPDATE ON TIPIFARNIB AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
Select another date:
- Playing The Expectations Game In Biotech
- Institutional Top Ideas: Great Point Partners
- A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals
- Institutional Top Ideas: EcoR1 Capital
- Kura Oncology's (KURA) CEO Troy Wilson on Q1 2018 Results - Earnings Call Transcript
- Your Daily Pharma Scoop: Portola's New Interim Data, Lantheus Announces Promising Data For LMI 1195, Kura Tumbles On Update